Feb 2024 $100 M No. 5 $50 to $250 million 31
Applied Therapeutics Inc.: Raise no. 5, Feb 2024 × Investors in this round 31 investors had bought by the notice of Mar 13, 2024: 31 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $100 M of $100 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $7,499,850
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Adam Hansard · Executive Officer · Chief Commercial Officer Catherine Thorpe · Executive Officer · Chief Accounting Officer Les Funtleyder · Executive Officer, Director · Chief Financial Officer and Director Riccardo Perfetti · Executive Officer · Chief Medical Officer Shoshana Shendelman · Executive Officer, Director · President and Chief Executive Officer Jay S. Skyler · Director Joel S. Marcus · Director Stacy J. Kanter · Director Teena J. Lerner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Robert W. Baird & Co. Inc. (CRD 8158) · Milwaukee, Wisconsin Sold in CA, CO, CT, FL, IL, MA, MD, NJ, NY, PA, UT RBC Capital Markets, LLC (CRD 31194) · New York, New York Sold in CA, CO, CT, FL, IL, MA, MD, NJ, NY, PA, UT Leerink Partners LLC (CRD 39011) · Boston, Massachusetts Sold in CA, CO, CT, FL, IL, MA, MD, NJ, NY, PA, UT UBS Securities LLC (CRD 7654) · New York, New York Sold in CA, CO, CT, FL, IL, MA, MD, NJ, NY, PA, UT Signed by Shoshana Shendelman, Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 13, 2024. Read the notice at the SEC .
equity, options SEC Apr 2023 $30 M No. 4 $10 to $50 million 19
Applied Therapeutics Inc.: Raise no. 4, Apr 2023 × Investors in this round 19 investors had bought by the notice of May 5, 2023: 19 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $30 M of $30 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $2,100,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Adam Hansard · Executive Officer · Chief Commercial Officer Riccardo Perfetti · Executive Officer · Chief Medical Officer Shoshana Shendelman · Executive Officer, Director · President, CEO and Chair of the Board of Directors Jay S. Skyler · Director Joel S. Marcus · Director Les Funtleyder · Director Stacy J. Kanter · Director Teena J. Lerner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round UBS Securities LLC (CRD 7654) · New York, New York Sold in CA, IL, MA, MD, NY SVB Securities LLC (CRD 39011) · New York, New York Sold in CA, IL, MA, MD, NY Signed by Shoshana Shendelman, Chief Executive Officer. Source: SEC Form D, newest notice filed May 5, 2023. Read the notice at the SEC .
equity, options SEC Nov 2019 $20 M No. 3 $10 to $50 million 12
Applied Therapeutics Inc.: Raise no. 3, Nov 2019 × Investors in this round 12 investors had bought by the notice of Nov 21, 2019: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $20 M of $20 M offered
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,250,449
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Mark Vignola · Executive Officer · Chief Financial Officer Riccardo Perfetti · Executive Officer · Chief Medical Officer Shoshana Shendelman · Executive Officer, Director · President, CEO and Chair of the Board of Directors Jay S. Skyler · Director Joel S. Marcus · Director Les Funtleyder · Director Stacy J. Kanter · Director Teena J. Lerner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round UBS Securities LLC · New York, New York Sold in CA, IL, MA, NY, VA John Dexter Pearson (CRD 6093501) · broker-dealer Collage Partners, a division of CIM Securities LLC (CRD 120852) · New York, New York Sold in CA, IL, NY, TX, VA Cowen and Company, LLC · New York, New York Sold in CA, IL, MA, NY, VA Signed by Mark Vignola, Chief Financial Officer. Source: SEC Form D, newest notice filed Nov 21, 2019. Read the notice at the SEC .
equity SEC Nov 2018 $27 M No. 2 $10 to $50 million 37
Applied Therapeutics Inc.: Raise no. 2, Nov 2018 × Investors in this round 37 investors had bought by the notice of Nov 19, 2018: 37 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $27 M of $57 M offered; $29 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $521,713
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Shoshana Shendelman · Executive Officer, Director Franklin Berger · Director Joel Marcus · Director Les Funtleyder · Director Teena Lerner · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round CIM Securities, LLC (CRD 120852) · New York, New York Sold in CA, CO, CT, FL, MI, NJ, NV, NY, OH, TX, WY Signed by Shoshana Shendelman, President and Secretary. Source: SEC Form D, newest notice filed Nov 19, 2018. Read the notice at the SEC .
equity, options SEC Jan 2017 $6 M No. 1 $2 to $10 million 26
Applied Therapeutics Inc.: Raise no. 1, Jan 2017 × Investors in this round 26 investors had bought by the notice of Feb 8, 2017: 26 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 5 investors are named for Applied Therapeutics Inc. as a whole in other filings: see Investors below.
What the notice says
Amount sold $6 M of $7 M offered; $1 M still to sell
Smallest investment taken no minimum stated
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $560,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks sales commissions as estimates
The company Corporation, incorporated in Delaware People named in the notice Shoshana Shendelman · Executive Officer, Director Les Funtleyder · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round Brookline Capital Market (CRD 120852) · broker-dealer a division of CIM Securities, LLC (CRD 120852) · New York, New York Sold in AL, CA, CO, CT, FL, IL, MI, MS, NJ, NY, TX, WI, WY Remarks in the notice On fees: “$490,000 reflects the cash sales commission to a broker and $70,000 reflects the value of the discount the broker receives when purchasing shares.”On the use of proceeds: “Other than the payment of salaries and other compensation and benefits in the ordinary course, no persons required to be named as executive officers, directors or promoters in response to Item 3 will receive any payment from the proceeds of this offering.”Signed by Shoshana Shendelman, President and Secretary. Source: SEC Form D, newest notice filed Feb 8, 2017. Read the notice at the SEC .
equity SEC